Any trial off therapy should be clinician-guided with alternative supports in place, as medication pauses typically lead to weight regain without a comprehensive plan
Further reading [edit] "Dulaglutide: An Evidence-Based Review of Its Potential in the Treatment of Type 2 Diabetes"
Patients with diabetes already face a higher risk of atrial fibrillation, so understanding how these GLP-1 receptor agonists affect cardiac electrophysiology is essential
Facial & Skin-Focused Formulations Commonly incorporated into protocols designed to support: Hair & Scalp Formulations Commonly incorporated into protocols designed to support: Learn more about the growing role peptides may play in provider-directed care strategies across wellness, aesthetics, and personalized medicine
The case settled in March 2026: Novo dropped the lawsuit in exchange for Hims agreeing to transition its platform entirely to authorized, branded semaglutide products and to cease all advertising of compounded GLP-1 alternatives
What does it feel like to take GLP-1s